Friday · October 9, 2026
Emerging

A Hidden Compound in ‘Healthy’ Plant Foods May Be Fueling Gut Inflammation

A new study ties oxalate, a compound in virtually all plant foods, to reduced gut transporter activity in IBD patients and worsened colitis in mice, though human causation remains unproven.

A Hidden Compound in 'Healthy' Plant Foods May Be Fueling Gut Inflammation

If you've spent any time trying to calm a flare of Crohn's disease or ulcerative colitis through diet, you already know how little solid guidance exists. A new study offers a specific, testable reason why "eat more plants" doesn't always help: oxalate, a compound present in nearly every plant food, appears to interact badly with an already-compromised gut lining in people with inflammatory bowel disease (IBD). The research, combining human tissue data with mouse experiments, does not prove oxalate causes IBD or flares in people, but it gives doctors and patients a new, concrete mechanism worth watching.

KEY TAKEAWAYS

  • People with Crohn's disease and ulcerative colitis show consistently lower levels of the gut proteins that normally clear oxalate from the intestine, especially in actively inflamed tissue.
  • In mice, adding oxalate to the diet made chemically induced colitis far more severe, cutting survival odds by 60 percent compared to other groups.
  • The human findings are correlational, drawn from tissue and stool samples, not a clinical trial. Nobody has data yet on whether cutting oxalate from the diet changes outcomes in people with IBD.

Oxalate Transporters Drop in Crohn's and Colitis Patients

Researchers found that three gut proteins called SLC26A2, SLC26A3, and SLC26A6 (transporters, meaning proteins that shuttle specific molecules across the intestinal lining) are consistently turned down in people with inflammatory bowel disease compared with people who don't have it. The team, led by scientists at the University of North Carolina at Chapel Hill and published in Cellular and Molecular Gastroenterology and Hepatology, measured gene activity in colon and ileum (the final section of the small intestine) tissue from people with Crohn's disease, ulcerative colitis, and comparison patients without IBD. SLC26A2 and SLC26A3, the transporters most responsible for absorbing oxalate out of the gut, were lower across every IBD subtype and every tissue type tested. In a paired analysis that compared inflamed and non-inflamed tissue from the same ulcerative colitis patients, expression dropped even further specifically in the inflamed spots, a statistically significant difference that suggests the problem gets worse exactly where and when disease is most active.

Crohn's and Ulcerative Colitis Patients Have the Most at Stake

This matters most for people already managing Crohn's disease or ulcerative colitis, two forms of IBD that affect roughly the same parts of the gut this study examined. With fewer working oxalate transporters, patients with Crohn's disease in the study had higher oxalate content in their stool than non-IBD comparison patients, even though dietary surveys and a molecular measure of plant intake (metabarcoding, meaning sequencing stool DNA to estimate what plants someone has eaten) showed no real difference in how much oxalate-containing food the two groups ate. In other words, the oxalate buildup looked like a transport problem, not an eating problem. The study also linked transporter levels to real clinical outcomes: among Crohn's patients, 74.5% of those with the lowest SLC26A6 expression had stricturing disease, a complication where the intestine narrows and scars, often eventually requiring surgery.

How the Study Combined Patient Tissue With Mouse Colitis Models

This finding carries more weight because it didn't rest on human data alone: the researchers paired patient observations with mouse experiments, the only way to test cause and effect directly. They first confirmed the human pattern held up across three separate patient cohorts in colon and ileal tissue. Then, in mice, they added oxalate to the diet and triggered colitis using dextran sodium sulfate (DSS), a chemical that damages the gut lining and is a standard way to model IBD-like inflammation in animals. Mice fed the oxalate-supplemented diet alongside DSS were 60% less likely to survive than mice on any other combination of diet and treatment, and they lost more weight, had shorter colons, and showed higher levels of inflammatory markers that persisted into the recovery period. The same oxalate diet also sped up colitis in two separate mouse strains bred to develop the disease spontaneously, and lab-dish experiments showed oxalate directly provoked inflammatory signaling in immune cells called macrophages and dendritic cells.

What This Means If You're Managing IBD

None of this means oxalate-rich foods are proven to worsen IBD in humans, and this study did not test a low-oxalate diet in people with Crohn's disease or ulcerative colitis. Spinach, rhubarb, beets, and almonds are commonly cited as high-oxalate foods by resources like the University of Chicago's kidney stone program, but this study did not test any specific food, only purified oxalate added to a controlled diet. It does suggest a plausible reason some patients may be more sensitive to a plant-forward diet than others: their gut may simply be worse at clearing oxalate out. If you have IBD and suspect certain plant-heavy meals coincide with flares, this is a legitimate, specific question to bring to a gastroenterologist rather than a reason to start restricting vegetables on your own. General nutrition guidance for Crohn's disease, such as NIDDK's eating and diet recommendations, still emphasizes working with a doctor or dietitian rather than self-directed elimination diets.

The Key Limitation: This Is Correlation in Humans, Not Proof

The central caveat: the human side of this study is correlational, built from a relatively small number of tissue and stool samples, and the authors call it hypothesis-generating. The causal evidence, that oxalate actually worsens inflammation and not just that it's found alongside it, comes entirely from the mouse experiments, not from a human trial. The mice were also fed a diet with 1% added oxalate, well above the roughly 100 to 150 milligrams per day a typical person eats, a concentration researchers use specifically to produce measurable effects in a short window rather than to mimic everyday human exposure. The authors note dietary intake data in patients wasn't collected at the same time as the stool samples that showed elevated oxalate, a gap they partly addressed with the DNA-based diet measurement but not perfectly.

Next Steps: Bigger Trials and Microbiome-Based Therapies

The researchers say this needs larger, longer human studies that directly measure oxalate intake, gut gene activity, and outcomes in the same patients over time, particularly those with stricturing Crohn's disease, where the SLC26A6 signal was strongest. Rather than pointing toward stricter low-oxalate diets, which are hard to sustain and could reduce intake of otherwise healthy foods, the authors point to the gut microbiome itself as a more promising target. Some gut bacteria, including Oxalobacter formigenes, can break oxalate down before it ever causes trouble, and that pathway is diminished in people with IBD. Future work may focus on restoring or boosting that bacterial function instead of asking patients to avoid healthy foods outright.

Common Questions

Should people with IBD stop eating spinach, almonds, or other high-oxalate foods? Not based on this study. The research didn't test whether reducing oxalate intake improves symptoms or outcomes in people with IBD, so cutting these foods isn't an established intervention. It's a reasonable topic to raise with a gastroenterologist, not a self-directed diet change.

Is oxalate bad for everyone, or just people with IBD? Oxalate is a normal part of most plant-based diets and isn't considered harmful for the general population at typical intake levels. This study suggests people with IBD specifically may handle oxalate less efficiently because of reduced transporter activity in the gut.

What exactly do SLC26A2, SLC26A3, and SLC26A6 do? They're transporter proteins in the intestinal lining that help move oxalate (and other molecules) into or out of the gut. When their activity drops, less oxalate gets absorbed and cleared normally, leaving more of it in the intestine.

Could gut bacteria eventually treat this instead of a special diet? That's the direction the study's authors point to. Certain gut bacteria can degrade oxalate before it causes problems, and restoring that bacterial function is being explored as a potentially more sustainable approach than long-term dietary restriction.

Evidence Rating

EMERGING — 86/100

Caveats

  • Human findings correlational; causal evidence is from mouse experiments, not a human trial.

Combines human IBD cohort data and mouse colitis experiments; dietary oxalate linked to worsened gut inflammation via reduced transporter expression, causality in humans not yet established.

References

  1. Anna C. Salvador, Zena Khaled, Ayesh Awad, et al. (2026). Dietary Oxalate and Intestinal Inflammation: Evidence From Experimental Colitis and Inflammatory Bowel Disease Patient Cohorts. Cellular and Molecular Gastroenterology and Hepatology. https://doi.org/10.1016/j.jcmgh.2026.101861
  2. How to Eat a Low Oxalate Diet. kidneystones.uchicago.edu. https://kidneystones.uchicago.edu/2015/11/16/how-to-eat-a-low-oxalate-diet/
  3. Eating, Diet, & Nutrition for Crohn's Disease. NIH. https://www.niddk.nih.gov/health-information/digestive-diseases/crohns-disease/eating-diet-nutrition
  4. Menghan Liu, Joseph C Devlin, Jiyuan Hu, et al. (2021). Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease. eLife. https://doi.org/10.7554/elife.63642